Dig Dis Sci. 2008 Aug;53(8):2059-65. Epub 2008 Jan 26.

Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20 mg in healthy subjects: a randomized, double-blind, placebo-controlled study.

Desai JC, Sanyal SM, Goo T, Benson AA, Bodian CA, Miller KM, Cohen LB, Aisenberg J.

Source

Department of Medicine (Gastroenterology), The Mount Sinai School of Medicine, New York, NY 10075-0903, USA.

Abstract

The effectiveness of low-dose omeprazole as primary prevention of gastrointestinal adverse events due to episodic use of non-selective NSAIDs was evaluated. Healthy adults aged 50-75 who did not take chronic NSAIDs were randomized to a 6.5-day treatment of naproxen 500 mg twice daily plus omeprazole 20 mg daily or naproxen 500 mg twice daily plus placebo. Seventy subjects were enrolled (mean age 58.6 years, proportion >60 = 41.4%). Subjects receiving naproxen plus omeprazole developed fewer gastroduodenal ulcers compared to subjects receiving naproxen plus placebo (11.8% vs. 46.9%, P = 0.002). Likewise, naproxen plus omeprazole was associated with a decreased risk of ulceration and/or >5 erosions (38.2% vs. 81.3%, P < or = 0.001), and a smaller change in dyspepsia score. Considering their relatively low cost, ready availability, and favorable safety profile, low-dose PPI co-prescription in healthy adults requiring short-term therapy with non-selective NSAIDs may be reasonable.

PMID:: 18224442; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. [Clin Ther. 2006]
A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S. Clin Ther. 2006 Mar; 28(3):340-51.
Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial. [Clin Gastroenterol Hepatol. 2007]
Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
Goldstein JL, Cryer B, Amer F, Hunt B. Clin Gastroenterol Hepatol. 2007 Oct; 5(10):1167-74.
Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. [Am J Med. 2005]
Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK. Am J Med. 2005 Nov; 118(11):1271-8.
Review Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications. [Am J Med. 2004]
Review Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications.
Peura DA. Am J Med. 2004 Sep 6; 117 Suppl 5A:63S-71S.
Review Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. [Health Technol Assess. 2008]
Review Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS. Health Technol Assess. 2008 Apr; 12(11):1-278, iii.

See reviews... See all...

Cited by 1 PubMed Central article

NSAID-induced antral ulcers are associated with distinct changes in mucosal gene expression. [Aliment Pharmacol Ther. 2009]
NSAID-induced antral ulcers are associated with distinct changes in mucosal gene expression.
Desai JC, Goo T, Fukata M, Sanyal S, Dikman A, Miller K, Cohen L, Brooks A, Wang Q, Abreu MT, et al. Aliment Pharmacol Ther. 2009 Jul; 30(1):71-81. Epub 2009 Mar 19.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Primary prevention of adverse gastroduodenal effects from short-term use of non-...
Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20 mg in healthy subjects: a randomized, double-blind, placebo-controlled study.
Dig Dis Sci. 2008 Aug ;53(8):2059-65. Epub 2008 Jan 26 .

PubMed
Trastuzumab monotherapy versus combination therapy for treating recurrent breast...
Trastuzumab monotherapy versus combination therapy for treating recurrent breast cancer: time to progression and survival.
Breast Cancer. 2008 ;15(1):57-64.

PubMed
[A clinical challenge. Pragmatic treatment of migraine and concomitant depressio...
[A clinical challenge. Pragmatic treatment of migraine and concomitant depression].
Schmerz. 2008 Feb ;22 Suppl 1:11-6.

PubMed
Alterations of the visual pathways in congenital blindness.
Alterations of the visual pathways in congenital blindness.
Exp Brain Res. 2008 May ;187(1):41-9. Epub 2008 Jan 26 .

PubMed
Dense deposit disease and the factor H H402 allele.
Dense deposit disease and the factor H H402 allele.
Clin Exp Nephrol. 2008 Jun ;12(3):228-32. Epub 2008 Jan 26 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20 mg in healthy subjects: a randomized, double-blind, placebo-controlled study.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information